MINARIS Trademark

Trademark Overview


On Thursday, July 16, 2020, a trademark application was filed for MINARIS with the United States Patent and Trademark Office. The USPTO has given the MINARIS trademark a serial number of 90057531. The federal status of this trademark filing is REGISTERED as of Tuesday, August 23, 2022. This trademark is owned by HITACHI CHEMICAL COMPANY, LTD.. The MINARIS trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Contract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; information, advice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapies, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration

Medical services, namely, contracted cell culturing and tissue culturing for medical purposes; medical advisory services, namely, advisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical services, namely, separation and cultivation of body tissues and cells for medical purposes; information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medical, medicinal and pharmaceutical consultancy; isolation, collection and preservation of blood components including cells or stem cells obtained from umbilical cord blood, bone marrow, placenta and other parts of the human body, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, and cells of human or animal origin

Pharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnology, and advisory services relating thereto; contracted development of biological cell manufacturing process; scientific laboratory...
minaris

General Information


Serial Number90057531
Word MarkMINARIS
Filing DateThursday, July 16, 2020
Status700 - REGISTERED
Status DateTuesday, August 23, 2022
Registration Number6823488
Registration DateTuesday, August 23, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements


Goods and ServicesContract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; information, advice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapies, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration
Description of MarkThe mark consists of two slightly overlapping hexagons, one blue and one green, each surrounded by a curved half circle, one blue and one green and the stylized wording "MINARIS" in blue.
Indication of Colors claimedThe color(s) green and blue is/are claimed as a feature of the mark.
Goods and ServicesMedical services, namely, contracted cell culturing and tissue culturing for medical purposes; medical advisory services, namely, advisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical services, namely, separation and cultivation of body tissues and cells for medical purposes; information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medical, medicinal and pharmaceutical consultancy; isolation, collection and preservation of blood components including cells or stem cells obtained from umbilical cord blood, bone marrow, placenta and other parts of the human body, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, and cells of human or animal origin
Goods and ServicesPharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnology, and advisory services relating thereto; contracted development of biological cell manufacturing process; scientific laboratory services, namely, the cultivation or modification of hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration into living drugs.; quality control services in the field of cell culture and tissue culture, and consultancy relating thereto; quality control of cell and living tissue for others

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, August 13, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 13, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 13, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRESONAC CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type29 - NOT AVAILABLE
AddressTOKYO 105-8518
JP

Party NameSHOWA DENKO MATERIALS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type29 - NOT AVAILABLE
AddressCHIYODA-KU, TOKYO 100-6606
JP

Party NameSHOWA DENKO MATERIALS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type29 - NOT AVAILABLE
AddressCHIYODA-KU, TOKYO 100-6606
JP

Party NameSHOWA DENKO MATERIALS CO., LTD.
Party Type11 - New Owner Before Publication
Legal Entity Type29 - NOT AVAILABLE
AddressCHIYODA-KU, TOKYO 100-6606
JP

Party NameHITACHI CHEMICAL COMPANY, LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChiyoda-ku, Tokyo 100-6606
JP

Trademark Events


Event DateEvent Description
Monday, July 20, 2020NEW APPLICATION ENTERED
Thursday, August 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Wednesday, January 6, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 25, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 14, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 6, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 6, 2020NON-FINAL ACTION E-MAILED
Tuesday, October 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2021SUSPENSION LETTER WRITTEN
Friday, September 17, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, February 18, 2021LETTER OF SUSPENSION E-MAILED
Thursday, February 18, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 28, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 14, 2021SUSPENSION INQUIRY WRITTEN
Thursday, October 14, 2021INQUIRY TO SUSPENSION E-MAILED
Thursday, October 14, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, March 2, 2022ASSIGNED TO LIE
Thursday, March 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, May 3, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, July 11, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 23, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED